Literature DB >> 27966197

Ruptured Aneurysms of Collateral Vessels in Adult Onset Moyamoya Disease with Hemorrhagic Presentation.

Jong Kook Rhim1, Young Dae Cho2, Jin Pyeong Jeon3, Dong Hyun Yoo4, Won-Sang Cho5, Hyun-Seung Kang5, Jeong Eun Kim5, Moon Hee Han4,5.   

Abstract

PURPOSE: Strategies for treating intracranial aneurysms of collateral vessels in adult onset moyamoya disease (MMD) remain unclear, because overall case numbers are limited and data on long-term outcomes are lacking. The aim of this study was to assess clinical and anatomic outcomes of such aneurysms in adult MMD sufferers who present with hemorrhage.
METHODS: Of the 77 adult patients consecutively enrolled between January 2003 and December 2014 in the MMD registry at a single institution, those presenting with hemorrhage and followed for >12 months were studied. Aneurysms involving collateral vessels at sites of hemorrhage were considered culprit lesions.
RESULTS: Aneurysms of collateral vessels in 19 patients (19/77, 24.7%) were confirmed as ruptured by conventional angiography. In five of these patients, obliterative endovascular embolization was successfully performed. The other 14 patients were managed conservatively due to lesion inaccessibility, and follow-up imaging studies (13 available) confirmed later disappearance of aneurysms in 12 patients (92.3%). In the aneurysm group (n = 19), re-bleeding occurred in 8 patients (42.1%) during follow-up (mean 67.4 ± 38.9 months). The re-bleeding involved contralateral hemispheres in 6 patients (75.0%), and all re-bleeding events occurred >6 months after initial hemorrhage. In the other 58 subjects without aneurysms 13 (22.4%) also suffered re-bleeding (mean follow-up 71.9 ± 46.3 months).
CONCLUSION: Although endovascular interventions are appropriate for ruptured aneurysms of collateral arteries in MMD, conservative treatment can be a viable alternative for technically inaccessible lesions.

Entities:  

Keywords:  Aneurysm; Collateral vessel; Hemorrhage; Moyamoya disease

Mesh:

Year:  2016        PMID: 27966197     DOI: 10.1007/s00062-016-0554-8

Source DB:  PubMed          Journal:  Clin Neuroradiol        ISSN: 1869-1439            Impact factor:   3.649


  17 in total

1.  Clinical features of adult moyamoya disease with special reference to the diagnosis.

Authors:  Jeong Eun Kim; Kang Min Kim; Jeong Gyun Kim; Hyun-Seung Kang; Jae Seung Bang; Young-Je Son; Moon Hee Han; Chang Wan Oh
Journal:  Neurol Med Chir (Tokyo)       Date:  2012       Impact factor: 1.742

Review 2.  Moyamoya disease: recent progress and outlook.

Authors:  Jun C Takahashi; Susumu Miyamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2010       Impact factor: 1.742

Review 3.  Moyamoya disease: current concepts and future perspectives.

Authors:  Satoshi Kuroda; Kiyohiro Houkin
Journal:  Lancet Neurol       Date:  2008-11       Impact factor: 44.182

4.  Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: An extensive follow-Up study.

Authors:  Y Yoshida; T Yoshimoto; R Shirane; Y Sakurai
Journal:  Stroke       Date:  1999-11       Impact factor: 7.914

5.  Evaluation of angiographic changes of the anterior choroidal and posterior communicating arteries for predicting cerebrovascular lesions in adult moyamoya disease.

Authors:  Wenhua Liu; Shuanggen Zhu; Xiaoliang Wang; Xuanye Yue; Zhiming Zhou; Handong Wang; Gelin Xu; Changsheng Zhou; Xinfeng Liu
Journal:  J Clin Neurosci       Date:  2011-01-14       Impact factor: 1.961

6.  [Significance of intracranial aneurysms associated with moyamoya disease. (Part I). Differences between intracranial aneurysms associated with moyamoya disease and usual saccular aneurysms--review of the literature].

Authors:  R Kwak; S Ito; N Yamamoto; S Kadoya
Journal:  Neurol Med Chir (Tokyo)       Date:  1984-02       Impact factor: 1.742

7.  Long term outcome after conservative and surgical treatment of haemorrhagic moyamoya disease.

Authors:  Xingju Liu; Dong Zhang; Wang Shuo; Yuanli Zhao; Rong Wang; Jizong Zhao
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-09-25       Impact factor: 10.154

8.  Endovascular treatment of ruptured aneurysms or pseudoaneurysms on the collateral vessels in patients with moyamoya disease.

Authors:  Seong Hyun Kim; O-Ki Kwon; Chul Kyu Jung; Hyun-Seung Kang; Chang Wan Oh; Moon Hee Han; Yong Sun Kim; Seung Kug Baik
Journal:  Neurosurgery       Date:  2009-11       Impact factor: 4.654

9.  Angiographic dilatation and branch extension of the anterior choroidal and posterior communicating arteries are predictors of hemorrhage in adult moyamoya patients.

Authors:  Motohiro Morioka; Jun-Ichiro Hamada; Takayuki Kawano; Tatemi Todaka; Shigetoshi Yano; Yutaka Kai; Yukitaka Ushio
Journal:  Stroke       Date:  2003-01       Impact factor: 7.914

10.  Resolution of bilateral moyamoya associated collateral vessel aneurysms: Rationale for endovascular versus surgical intervention.

Authors:  Sepideh Amin-Hanjani; Sean Goodin; Fady T Charbel; Ali Alaraj
Journal:  Surg Neurol Int       Date:  2014-06-19
View more
  3 in total

Review 1.  The prospects and pitfalls in the endovascular treatment of moyamoya disease-associated intracranial aneurysms.

Authors:  Kun Hou; Guichen Li; Tengfei Luan; Kan Xu; Jinlu Yu
Journal:  Neurosurg Rev       Date:  2020-02-12       Impact factor: 3.042

2.  Analysis of the clinical characteristics of hemorrhagic moyamoya disease in the Jilin province of northeastern China: A single-center study of 212 cases.

Authors:  Qinglian Li; Lai Qu; Yongjie Yuan; Baofeng Xu; Yunbao Guo; Kan Xu; Jinlu Yu
Journal:  Biomed Rep       Date:  2017-12-15

3.  Development and natural course of lateral posterior choroidal artery aneurysms arising from fragile choroidal collaterals in moyamoya disease: illustrative cases.

Authors:  Tomoaki Suzuki; Hitoshi Hasegawa; Kouichirou Okamoto; Kazuhiro Ando; Kohei Shibuya; Haruhiko Takahashi; Shoji Saito; Makoto Oishi; Yukihiko Fujii
Journal:  J Neurosurg Case Lessons       Date:  2021-04-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.